as on January 8, 2026 at 2:29 am IST
Day's Low
Day's High
1.71%
Downside
5.13%
Upside
52 Week's Low
52 Week's High
75.76%
Downside
41.88%
Upside
Check Lexicon Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$414.3M
EPS (TTM)
-0.1669
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.63%
PE Ratio (TTM)
-3.22
Industry PE ratio
-2.796053811659193
PEG Ratio
-0.14
EBITDA
-53.9M
Revenue (TTM)
70.9M
Profit Margin
-96.77%
Return On Equity TTM
-45.92%
Track how Lexicon Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Lexicon Pharmaceuticals, Inc. in the last 5 years
Lowest (-57.70x)
March 31, 2021
Today (-3.22x)
January 7, 2026
Industry (-2.80x)
January 7, 2026
Highest (12.67x)
June 30, 2021
Today’s Price to Earnings Ratio: -3.22x
Compare market cap, revenue, PE, and other key metrics of Lexicon Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $414.3M | -68.94% | -3.22 | -96.77% | |
| BUY | $37.3B | 414.46% | -16.34 | -264.83% | |
| BUY | $52.6B | 191.54% | 1243.22 | 1.36% | |
| BUY | $115.1B | 101.11% | 31.54 | 31.35% | |
| BUY | $80.9B | 61.38% | 18.28 | 32.13% |
The Lexicon Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lexicon Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,30,516
Returns
₹30,516
(+30.52%)
Returns from Lexicon Pharmaceuticals, Inc. Stock
₹25,806 (+25.81%)
Dollar Returns*
₹4,709 (+4.71%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Lexicon Pharmaceuticals, Inc.. Average target price of $2.88
Get share price movements and forecasts by analysts on Lexicon Pharmaceuticals, Inc..
What analysts predicted
59.38%UPSIDE
Target Price
$2.88
Current Price
$1.17
Analyzed by
11 Analysts
Target
$2.88
Lexicon Pharmaceuticals, Inc. target price $2.88, a slight upside of 59.38% compared to current price of $1.17. According to 11 analysts rating.
Search interest for Lexicon Pharmaceuticals, Inc. Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 164.8% return, outperforming this stock by 142.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 846.3% return, outperforming this stock by 893.0%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 3.25M → -12.76M (in $), with an average decrease of 492.7% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 28.86M → 14.18M (in $), with an average decrease of 50.9% per quarter
Price Dip
![]()
In the last 1 month, LXRX stock has moved down by -18.6%
| Organisation | Lexicon Pharmaceuticals, Inc. |
| Headquarters | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
| Industry | Health Technology |
| CEO | Dr. Michael S. Exton Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Michael S. Exton Ph.D. | CEO & Director |
Mr. Brian T. Crum | Senior VP, General Counsel & Secretary |
Ms. Lisa M. DeFrancesco | Senior Vice President of Investor Relations & Corporate Communications |
Mr. Dixon Terry | Vice President of Compliance |
Ms. Carrie Siragusa | Vice President of Marketing |
Ms. Desiree Gendron | Vice President of Sales & Training |
Ms. Wendy E. McDermott | Senior Vice President of Human Resources |
Ms. Kristen L. Alexander | Vice President of Finance & Accounting |
Dr. Craig B. Granowitz M.D., Ph.D. | Senior VP & Chief Medical Officer |
Mr. Scott M. Coiante | Senior VP & CFO |
Lexicon Pharmaceuticals, Inc. share price today is $1.17 as on at the close of the market. Lexicon Pharmaceuticals, Inc. share today touched a day high of $1.23 and a low of $1.15.
Lexicon Pharmaceuticals, Inc. share touched a 52 week high of $1.66 on and a 52 week low of $0.28 on . Lexicon Pharmaceuticals, Inc. stock price today i.e. is closed at $1.17,which is 29.52% down from its 52 week high and 312.55% up from its 52 week low.
Lexicon Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Lexicon Pharmaceuticals, Inc. (LXRX) shares with as little as ₹89.849 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.49 in Lexicon Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lexicon Pharmaceuticals, Inc. share’s latest price of $1.17 as on January 8, 2026 at 2:29 am IST, you will get 8.5470 shares of Lexicon Pharmaceuticals, Inc.. Learn more about
fractional shares .
Lexicon Pharmaceuticals, Inc. stock has given -68.94% share price returns and 22.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?